[Retracted] Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer

Table 2

Comparison of the incidence of adverse reactions between the two groups.

Group	Abnormal liver function	Nausea and vomiting	Thrombocytopenia	Reduced white blood cell count	Oral mucositis	Sensory nerve abnormalities
Treatment group	5	4	11	6	4	9
Control group	14	16	12	13	12	16
^2	11.783	12.451	0.765	5.562	4.671	3.781
	<0.05	<0.05	>0.05	<0.05	<0.05	<0.05